Article Details
Retrieved on: 2024-11-08 20:22:19
Tags for this article:
Click the tags to see associated articles and topics
Summary
Pfizer plans to invest $1 billion in China by 2030 to bolster biotech and drug R&D, contrasting with other U.S. companies shifting operations away from China. This strategy includes expanding COVID-19 vaccines and medical innovations.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here